Invesco S&P 500 Equal Weight Health Care ETF RSPH
41.27 USD -0.13 (-0.31%)
At closeNov 10, 2026, 4:00 PM EST
40.92 -0.35 -0.85%
After hours · Nov 10, 4:00 PM ET
40.89 Day range 41.35
29.56 52-week range 41.94
- YTD
- +29.58%
- 1 year
- +35.44%
News
fool.com Decoding Healthcare ETFs: Different Sectors, Different Strategies While State Street SPDR S&P Biotech ETF delivered a higher 1-year total return, the Invesco fund has experienced significantly shallower drawdowns and stronger cumulative growth over the past five…
fool.com Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT? FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.
fool.com Invesco's RSPH or iShares' IBB: Which Healthcare ETF Is the Better Long-Term Buy? Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and a higher dividend yield than iShares Biotechnology ETF. iShares Biotechnology ETF provides concentrated biotech exposure…
zacks.com S&P 500 Health Care ETF (RSPH) Touches New 52-Week High RSPH hits a new 52-week high, rising 29.5% from its low as resilient healthcare demand, solid earnings and defensive-sector appeal fuel momentum.
etftrends.com From Laggard to Leader: The Surprising Comeback of Healthcare Healthcare stocks have finally stepped back into the spotlight. After spending much of the past several years in the shadow of technology and AI, the sector has quietly emerged as one of the year's…
defenseworld.net 15,640 Shares of Invesco S&P 500 Equal Weight Health Care ETF $RSPH Bought by Avidian Wealth Enterprises LLC Avidian Wealth Enterprises LLC acquired a new stake in Invesco S&P 500 Equal Weight Health Care ETF (NYSEARCA:RSPH) during the third quarter, according to its most recent Form 13F filing with the…
fool.com Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens The Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and broader diversification than the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has generated higher…
zacks.com Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)? Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded…
fool.com PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? PBE offers a higher dividend yield and has delivered stronger one-year total returns. RSPH offers a more affordable expense ratio and a significantly lower historical drawdown.
fool.com Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. The Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to 26 for the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF currently offers a…
fool.com Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund? IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight healthcare approach generated 29%. Risk profiles differ sharply too.
zacks.com Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now? The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) was launched on 11/01/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the…
fool.com Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ? Invesco Nasdaq Biotechnology ETF has a lower expense ratio but higher price volatility than Invesco S&P 500 Equal Weight Health Care ETF. Invesco S&P 500 Equal Weight Health Care ETF holds fewer…
fool.com Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH The Invesco S&P 500 Equal Weight Health Care ETF provides broad exposure to the sector, while the State Street SPDR S&P Pharmaceuticals ETF focuses specifically on the pharmaceutical industry. The…
seekingalpha.com RSPH: One Of The Few Equal Weight ETFs I Follow Closely RSPH's valuation gap versus market weight peers has narrowed but not closed, with expected returns now roughly similar to XLV. RSPH's mid-cap tilt could in my opinion benefit more than XLV from…
benzinga.com Moderna Advances Ebola Vaccine Into Human Testing Moderna starts Phase 1 trials for Ebola vaccine mRNA-1469. See premarket MRNA stock reaction, analyst updates, and ETF exposure.
zacks.com Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)? Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded…
fool.com Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH? FHLC's 0.08% expense ratio and market-cap approach delivered stronger returns, while RSPH's equal-weight strategy offers lower volatility and broader diversification across 60 holdings.
fool.com IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy? IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return.
fool.com Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF iShares Global Healthcare ETF offers a higher dividend yield and lower volatility than Invesco S&P 500 Equal Weight Health Care ETF. Invesco S&P 500 Equal Weight Health Care ETF assigns identical…
fool.com Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026? Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to the 25 positions in VanEck Biotech ETF VanEck Biotech ETF has a slightly lower expense ratio of…
benzinga.com Centene (CNC) Stock Slides After Medicare Advantage Update Centene shares are trading sharply lower Tuesday morning after federal regulators outlined 2027 Medicare Advantage payment changes that amounted to effectively flat funding for insurers.
benzinga.com Apple, Western Union, Palo Alto And More On CNBC's 'Final Trades' Apple, Palo Alto and Western Union are among the companies mentioned on the latest edition of CNBC's "Final Trades."
benzinga.com Tesla And Amazon Just Became A Problem For The Entire Discretionary Sector The consumer discretionary sector is underperforming due to stock concentration in Tesla and Amazon, but smaller companies in the sector are quietly delivering steady gains.